New Getting It Right First Time leads announced
Clinical leads for three areas of the Getting It Right First Time programme have been announced.
The £60m clinical efficiency and safety programme is run by NHS Improvement and sees clinician led teams look at service lines in every trust in England to determine whether they are operating at sufficient scale, among other factors.
Some trusts change their practices or stop providing some services as a result of the subject area GIRFT reports published so far on orthopaedics and general surgery.
The programme announced clinical leads for endocrinology, rheumatology and stroke medicine last week.
The endocrinology team will be led by Professor John Wass, professor of endocrinology at Oxford University.
The rheumatology team is headed by Lesley Kay, consultant rheumatologist at Newcastle Upon Tyne Hospitals Foundation Trust, and chair of the British Society for Rheumatology Clinical Affairs Committee, and Peter Lanyon, consultant rheumatologist at Nottingham University Hospitals Trust and president of the BSR. Senior clinical adviser to the team is Professor Alex MacGregor, consultant rheumatologist at Norfolk and Norwich University Hospitals FT and chair of the BSR research committee.
The stroke medicine team’s clinical lead is Deborah Lowe from Wirral University Teaching Hospital FT, with East Kent University Hospitals FT’s David Hargroves as senior clinical adviser.
Professor Tim Briggs, GIRFT chair and national director of clinical quality and efficiency at NHS Improvement, said: “Our clinical leads are all experts in their field with a detailed knowledge of the clinical services within their specialty. The GIRFT programme has brought into sharp focus the differences in the way services are delivered and our clinical leads, who all understand the challenges, are committed to finding the solutions that will deliver sustainable, high quality services, improve patient outcomes and bring about efficiencies.”
Most of the 35 areas in the GIRFT portfolio already have a clinical director.
The next completed review will be on vascular surgery but its release date is not known.